| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +0.0% |
| R&D Expense | $45.0M | +39.8% |
| SG&A Expense | $11.8M | +9.6% |
| Operating Income | -$56.8M | -37.0% |
| Interest Expense | $54K | +31.7% |
| Pre-tax Income | -$54.4M | -34.1% |
| Income Tax | $147K | +712.5% |
| Net Income | -$54.6M | -34.5% |
| EPS (Basic) | -$0.48 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.5M | -43.0% |
| Current Assets | $68.0M | -41.9% |
| Total Assets | $70.4M | -40.3% |
| Current Liabilities | $11.2M | +12.4% |
| Total Liabilities | $11.5M | +14.6% |
| Stockholders' Equity | $58.9M | -45.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -39.5% |
| Financing Cash Flow | -$210K | -100.2% |
| -2.1% |
| EPS (Diluted) | -$0.48 | -2.1% |